Dar es Salaam. Tanzania Commercial Bank (TCB) has integrated its Popote mobile banking app with the Dar es Salaam Stock Exchange (DSE) trading platform in an effort to simplify the stock trading process.
This move allows TCB customers to access real-time market data, execute trades, and manage investment portfolios directly from their mobile devices.
The seamless integration means that customers can now engage in stock trading without needing to visit trading desks, making it easier to participate in the stock market from any location, whether at home, at work, or on the move.
“By integrating with the DSE trading platform, we’re not just simplifying the trading process, but also enhancing our digital footprint. This initiative reflects our commitment to providing secure, convenient, and innovative banking solutions,” TCB CEO Adam Mihayo said during the launch of the initiative at the weekend.
Mr Mihayo said the app was helping users diversify their portfolios and contribute to the nation’s economic growth. “This is a leap forward in empowering our customers to secure their financial future easily, combining traditional banking with modern investment opportunities.”
Gracing the event, Treasury Registrar Nehemiah Mchechu directed the DSE, CMSA and TCB to ensure that Tanzanians understand the significance of investing in stocks.
“We must encourage more Tanzanians to participate in capital market investments. This will expand investment opportunities, particularly for those who lack the means to start their own business,” Mr Mchechu said.
He said the shift could also provide an alternative source of capital for businesses, reducing the reliance on loans, which often result in debt burdens. The government, he said, was working on plans to increase the number of institutions listed on the stock exchange.
CMSA CEO Nicodemus Mkama said the new service would help reach citizens in areas where stock market services are limited, bringing investment opportunities to a wider audience.
“Many companies providing stock services are based in major cities like Dar es Salaam. With this collaboration, we’ll be able to reach people in other regions and enable them to participate in investments,” he said.
DSE CEO Peter Nalitolela said the stock market would continue to create an environment conducive to broader participation, ultimately strengthening Tanzania’s investment landscape.
The government’s push for broader participation in capital markets aligns with its goal to diversify investment opportunities and promote economic growth.
Share this news
This Year's Most Read News Stories
Africa: Rwanda Gets a Grip Of Marburg, But Mpox ‘Not Yet Under Control’
Monrovia — The Rwanda Minister of State responsible for Health, Dr. Yvan Butera, cautioned that while the country is beginning to see positive signals in its fight against the Marburg virus, the outbreak is “not yet over”. He, however, expressed hope that “we are headed in that direction”. The minister said the epidemiology trend, since the disease was first discovered in the country more than a month ago, is moving towards fewer cases.
Dr. Butera, who was giving updates during an online briefing yesterday, said in the past two weeks, only two deaths were recorded while 14 people recovered from the disease. He said Rwanda was expanding its testing capacity with 16,000 people already inoculated against the disease.
The priority right now, Butera said, is “rapid testing and detection”.
Marburg is a highly virulent disease transmitted through human-to-human contact or contact with an infected animal. The fatality rate of cases, which has varied over the period, is more than 50%, according to the World Health Organization. WHO said the highest number of new confirmed cases in Rwanda were reported in the first two weeks of the outbreak. There’s been a “sharp decline” in the last few weeks, with the country now tackling over 60 cases.
At Thursday’s briefing, a senior official of the Africa Centers for Disease Control, Dr. Ngashi Ngongo, said mpox – the other infectious disease outbreak that countries in the region are fighting – was been reported in 19 countries, with Mauritius being the latest country to confirm a case. He said although no new cases have been recorded in recent weeks in several countries where outbreaks occurred previously – including Cameroon, South Africa, Guinea, and Gabon – Uganda confirmed its first Mpox death. This, he said, is one of two fatalities reported outside Central Africa.
Dr. Ngashi revealed that there was an increase in cases in Liberia and Uganda. He said mpox cases were still on an upward trend.
“The situation is not yet under control.”
Source: allafrica.com
‘No Marburg Confirmed In Tanzania’, But Mpox Remains ‘Public Health Emergency’
Monrovia — The Director General of the African Centers for Disease Control, Jean Kaseya, has said the center stands ready to support Tanzania and other countries in the region where suspected cases of the infectious Marburg Virus Disease have been identified. The World Health Organization earlier this week issued an alert warning of a possible outbreak in the country, although the Tanzanian Health Ministry has said tests conducted on available samples did not show the existence of Marburg in the East African nation.
“As of the 15 of January 2025, laboratory results from all suspected individuals were negative for Marburg Virus,” Tanzanian Health Minister Jenista Mhagama said in a statement. This would have marked the country’s second experience with the highly infectious disease that recently killed over a dozen people in neighboring Rwanda. Tanzania previously reported an outbreak of Marburg in 2023 in the Kegara region, said to have been the epicenter of the new suspected cases.
At the Africa CDC online briefing on Thursday, Kaseya also said another infectious disease, Mpox, “remains a public health concern”. He said that while in December 2024, the disease had afflicted 20 countries, a new country – Sierra Leone – has been added to the number after recent outbreak there. Sierra Leonean health authorities said on January 10 that two cases of Mpox had been confirmed in the country and dozens of contacts are being traced.
With thousands of confirmed cases of Mpox across Africa and more than 1000 people having died of the disease – mainly in Central Africa – Kaseya emphasized the need to increase testing, a theme he’s heralded before. The Africa CDC boss said over the next few months the continental health watchdog will deploy additional epidemiologists and community health workers to areas considered hot spots of infectious diseases in the region.
Source: allafrica.com
Tanzania Confirms Outbreak of Marburg Virus Disease
Dodoma — Tanzania today confirmed an outbreak of Marburg virus disease in the northwestern Kagera region after one case tested positive for the virus following investigations and laboratory analysis of suspected cases of the disease.
President of the Republic of Tanzania, Her Excellency Samia Suluhu Hassan, made the announcement during a press briefing alongside World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, in the country’s administrative capital Dodoma.
“Laboratory tests conducted in Kabaile Mobile Laboratory in Kagera and later confirmed in Dar es Salaam identified one patient as being infected with the Marburg virus. Fortunately, the remaining suspected patients tested negative,” the president said. “We have demonstrated in the past our ability to contain a similar outbreak and are determined to do the same this time around.”
A total of 25 suspected cases have been reported as of 20 January 2025, all of whom have tested negative and are currently under close follow-up, the president said. The cases have been reported in Biharamulo and Muleba districts in Kagera.
“We have resolved to reassure the general public in Tanzania and the international community as a whole of our collective determination to address the global health challenges, including the Marburg virus disease,” said H.E President Hassan.
WHO is supporting Tanzanian health authorities to enhance key outbreak control measures including disease surveillance, testing, treatment, infection prevention and control, case management, as well as increasing public awareness among communities to prevent further spread of the virus.
“WHO, working with its partners, is committed to supporting the government of Tanzania to bring the outbreak under control as soon as possible, and to build a healthier, safer, fairer future for all the people of Tanzania,” said Dr Tedros. “Now is a time for collaboration, and commitment, to protecting the health of all people in Tanzania, and the region, from the risks posed by this disease.”
Marburg virus disease is highly virulent and causes haemorrhagic fever. It belongs to the same family as the virus that causes Ebola virus disease. Illness caused by Marburg virus begins abruptly. Patients present with high fever, severe headache and severe malaise. They may develop severe haemorrhagic symptoms within seven days.
“The declaration by the president and the measures being taken by the government are crucial in addressing the threat of this disease at the local and national levels as well as preventing potential cross-border spread,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Our priority is to support the government to rapidly scale up measures to effectively respond to this outbreak and safeguard the health of the population,”
Tanzania previously reported an outbreak of Marburg in March 2023 – the country’s first – in Kagera region, in which a total of nine cases (eight confirmed and one probable) and six deaths were reported, with a case fatality ratio of 67%.
Sign up for free AllAfrica Newsletters
Get the latest in African news delivered straight to your inbox
In the African region, previous outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of the Congo, Ghana, Kenya, Equatorial Guinea, Rwanda, South Africa and Uganda.
Marburg virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials. Although several promising candidate medical countermeasures are currently undergoing clinical trials, there is no licensed treatment or vaccine for effective management or prevention of Marburg virus disease. However, early access to treatment and supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improve survival.
Source: allafrica.com
